IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Showing posts with label reform. Show all posts
Showing posts with label reform. Show all posts
Tuesday, 23 April 2019

The Subcommittee on IP in U.S. Senate Reinstated; First Action is Patent Eligible Subject Matter Reform

›
Recently, several members of Congress have reinstituted the Subcommittee on Intellectual Property in the U.S. Senate.   This, in and of ...
Monday, 26 February 2018

Trump White House Releases Biopharmaceutical Pricing Reform White Paper

›
The White House Council of Economic Advisers recently released a report titled, “Reforming Biopharmaceutical Pricing at Home and Abroad....
›
Home
View web version
Powered by Blogger.